He L Catalogue en ligne

Détail de l'auteur

Auteur He L

Documents disponibles écrits par cet auteur (14)

trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche

Article

Cell communication and signaling : CCS, 22, 1. Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy

He L ; Zhong Z ; Wen S ; Li P ; Jiang Q ; Liu F | 03/04/2024

Plus d'information...

Ajouter au panier

En ligne

Article

Seminars in arthritis and rheumatism, 65. Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis

Jin Q ; Lin S ; Chen X ; Xu Y ; Tian X ; He L ; Jiang W ; Chen F ; Shu X ; Lu X ; Peng Q ; Wang G | 03/01/2024

Plus d'information...

Ajouter au panier

En ligne

Article

Chinese medicine, 18, 1. Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota

Weng S ; Huang L ; Cai B ; He L ; Wen S ; Li J ; Zhong Z ; Zhang H ; Huang C ; Yang Y ; Jiang Q ; Liu F | 04/08/2023

Plus d'information...

Ajouter au panier

En ligne

Article

Clinical rheumatology Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis

Wang Y ; Luo J ; Lv X ; Li Y ; An Q ; Mo L ; Hu N ; Zhang J ; Wang J ; Tian J ; Pu D ; Hao Z ; He L | Germany | 16/03/2023

Plus d'information...

Ajouter au panier

En ligne

Article

Journal of animal science and biotechnology, 13, 1. Ryanodine receptor RyR1-mediated elevation of Ca(2+) concentration is required for the late stage of myogenic differentiation and fusion

Qiu K ; Wang Y ; Xu D ; He L ; Zhang X ; Yan E ; Wang L ; Yin J | 11/02/2022

Plus d'information...

Ajouter au panier

En ligne

$The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study$

Article

Frontiers in pharmacology, 12. The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study

Li S ; Li W ; Jiang W ; He L ; Peng Q ; Wang G ; Lu X | 16/03/2021

Plus d'information...

Ajouter au panier

En ligne

Article

Therapeutic advances in neurological disorders, 14. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series

Xiong A ; Yang G ; Song Z ; Xiong C ; Liu D ; Shuai Y ; He L ; Zhang L ; Guo Z ; Shuai S | 12/03/2021

Plus d'information...

Ajouter au panier

En ligne

Article

EMBO Molecular Medicine, 12, 3. Metabolic effects of bezafibrate in mitochondrial disease

Steele H ; Gomez-Duran A ; Pyle A ; Hopton S ; Newman J ; Stefanetti RJ ; Charman SJ ; Parikh JD ; He L ; Viscomi C ; Jakovljevic DG ; Hollingsworth KG ; Robinson AJ ; Taylor RW ; Bottolo L ; Horvath R ; Chinnery PF | England | 03/2020

Plus d'information...

Ajouter au panier

En ligne

Article

Brain : a journal of neurology, 143, 1. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy

Kannan A ; Jiang X ; He L ; Ahmad S ; Gangwani L | England | 01/2020

Plus d'information...

Ajouter au panier

En ligne

Article

Mediators of inflammation Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity

He L ; Shu X ; Liu X ; Ge Y ; Li S ; Lu X ; Wang G | 2020

Plus d'information...

Ajouter au panier

En ligne

Article

Neurology. Genetics, 4, 4. Expanding the phenotype of de novo SLC25A4-linked mitochondrial disease to include mild myopathy

King MS, Auteur ; Thompson K ; Hopton S ; He L ; Kunji ERS ; Taylor RW ; Ortiz-Gonzalez XR | 20/07/2018

Plus d'information...

Ajouter au panier

En ligne

Article

The Cochrane database of systematic reviews, 12. Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders

Luo F, Auteur ; Annane D ; Orlikowski D ; He L ; Yang M ; Zhou M ; Liu GJ | 2017

Plus d'information...

Ajouter au panier

En ligne

Article

Biochimica et biophysica acta, 1802, 6. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy

Sanaker PS ; Toompuu M ; Hogan VE ; He L ; Tzoulis C ; Chrzanowska-Lightowlers ZMA ; Taylor RW ; Bindoff LA | 2010

Accès au résumé PubMed / to PubMed abstract

Plus d'information...

Ajouter au panier

Article

Annals of neurology, 63, 1. Prevalence of mitochondrial DNA disease in adults

Schaefer AM ; McFarland R ; Blakely EL ; He L ; Whittaker RG ; Taylor RW ; Chinnery PF ; Turnbull DM | 2008

Accès au résumé PubMed / to PubMed abstract 23/10/2007 - La prévalence des cytopathies mitochondriales sans doute sous-estimée Les maladies (ou cytopathies) mitochondriales) constituent un vaste ensemble de pathologies humaines don[...]

Plus d'information...

Ajouter au panier

MYOBASE

Newsletters

Bibliographies

Portail documentaire sur les maladies neuromusculaires

Se connecter

Accueil

Sélection de la langue

Adresse

Détail de l'auteur

Auteur He L

Documents disponibles écrits par cet auteur (14)

Cell communication and signaling : CCS, 22, 1. Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy

Seminars in arthritis and rheumatism, 65. Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis

Chinese medicine, 18, 1. Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota

Clinical rheumatology Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis

Journal of animal science and biotechnology, 13, 1. Ryanodine receptor RyR1-mediated elevation of Ca(2+) concentration is required for the late stage of myogenic differentiation and fusion

Frontiers in pharmacology, 12. The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study

Therapeutic advances in neurological disorders, 14. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series

EMBO Molecular Medicine, 12, 3. Metabolic effects of bezafibrate in mitochondrial disease

Brain : a journal of neurology, 143, 1. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy

Mediators of inflammation Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity

Neurology. Genetics, 4, 4. Expanding the phenotype of de novo SLC25A4-linked mitochondrial disease to include mild myopathy

The Cochrane database of systematic reviews, 12. Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders

Biochimica et biophysica acta, 1802, 6. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy

Annals of neurology, 63, 1. Prevalence of mitochondrial DNA disease in adults